A recent study examining the yield of 348 multi-gene tests not limited to breast cancer found that the inclusion of moderate-risk genes increased only the positive rate of “historically high-risk” cancer genes.26 Another study, which assessed 90 HBOC patients, found that the positive rate roughly doubled when the panel included genes beyond BRCA1/2. The gene discussed is BRCA1; the disease is breast cancer.